Compounding medication for digestive decontamination: Pharmaceutical aspects

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

To assess the effect of selective decontamination of the digestive tract on respiratory tract infections and survival of patients treated in an intensive care unit, meta-analyses of clinical studies comparing patients treated with selective decontamination and untreated controls have been carried out. Analyses of these studies have shown a protective effect of selective decontamination on infections. On the other hand, the mortality benefit has been shown only recently [1]. Earlier studies with historical controls and randomised trials showed that mortality was not significantly different between treatment and control patients. The evidence from these studies is consistent with an effect of selective decontamination of the digestive tract on survival of patients in the intensive care unit, in addition to a clear preventive effect on the occurrence of respiratory tract infections [2]-[12]. © 2008 Springer-Verlag Italia.

Cite

CITATION STYLE

APA

Schootstra, R., & Yska, J. P. (2008). Compounding medication for digestive decontamination: Pharmaceutical aspects. In Selective Digestive Tract Decontamination in Intensive Care Medicine: a Practical Guide to Controlling Infection (pp. 73–87). Springer Milan. https://doi.org/10.1007/978-88-470-0653-9_5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free